Albert K. Groen

Active 1978–2024

156
Papers
32,857
Citations
92
h-index
148
i10-index

Citations

Citations per year for Albert K. Groen1978: 1 citations1979: 3 citations1980: 4 citations1981: 3 citations1982: 5 citations1983: 9 citations1984: 13 citations1985: 21 citations1986: 26 citations1987: 22 citations1988: 23 citations1989: 18 citations1990: 32 citations1991: 21 citations1992: 18 citations1993: 25 citations1994: 26 citations1995: 31 citations1996: 60 citations1997: 73 citations1998: 78 citations1999: 68 citations2000: 91 citations2001: 81 citations2002: 90 citations2003: 115 citations2004: 101 citations2005: 112 citations2006: 154 citations2007: 91 citations2008: 101 citations2009: 105 citations2010: 107 citations2011: 112 citations2012: 121 citations2013: 165 citations2014: 216 citations2015: 266 citations2016: 355 citations2017: 446 citations2018: 523 citations2019: 1,309 citations2020: 1,683 citations2021: 1,794 citations2022: 1,620 citations2023: 1,277 citations2024: 1,814 citations2025: 1,075 citations2026: 33 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,262 citing papers, 18.9% of this breakdownChina: 2,948 citing papers, 17% of this breakdownNetherlands: 1,051 citing papers, 6.1% of this breakdownUnited Kingdom: 880 citing papers, 5.1% of this breakdownGermany: 762 citing papers, 4.4% of this breakdownItaly: 711 citing papers, 4.1% of this breakdownFrance: 597 citing papers, 3.5% of this breakdownCanada: 563 citing papers, 3.3% of this breakdownSpain: 438 citing papers, 2.5% of this breakdownAustralia: 414 citing papers, 2.4% of this breakdownJapan: 394 citing papers, 2.3% of this breakdownIndia: 371 citing papers, 2.1% of this breakdown
0%18.9%Other 28.3%

Fields

  • Biochemistry, Genetics and Molecular Biology45.1%
  • Medicine42.3%
  • Agricultural and Biological Sciences3.7%
  • Nursing3%
  • Immunology and Microbiology1.7%
  • Neuroscience1.4%
  • Other2.8%

Topics

  • Gut microbiota and health15.6%
  • Diet and metabolism studies7.5%
  • Liver Disease Diagnosis and Treatment3.8%
  • Drug Transport and Resistance Mechanisms3.8%
  • Clostridium difficile and Clostridium perfringens research3.3%
  • Probiotics and Fermented Foods2.4%
  • Other63.6%

Coauthors

All papers

Open in search
  1. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

    Authors: , , , , , - Journal of Lipid Research 2013 cited by 4,909

  2. Short chain fatty acids in human gut and metabolic health

    Authors: , , , , , , , , , , , , - Beneficial Microbes 2020 cited by 1,080

  3. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2012 cited by 2,850

  4. Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

    Authors: , , , , , , , , , , - Diabetes 2015 cited by 1,096

  5. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

    Authors: , , , , , , , , , , , , , , , - Gut 2017 cited by 665

  6. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 cited by 1,008

  7. Microbiome-derived ethanol in nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 202

  8. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 745

  9. Fecal SCFAs and SCFA‐producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T‐cell activation and advanced disease

    Authors: , , , , , , , , , - United European Gastroenterology Journal 2018 cited by 326

  10. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids

    Authors: , , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2013 cited by 603

  11. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 302

  12. Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology Communications 2020 cited by 143

  13. Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American Heart Association 2018 cited by 242

  14. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2013 cited by 579

  15. Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice

    Authors: , , , , , , , , , , , , - npj Biofilms and Microbiomes 2016 cited by 262

  16. Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation

    Authors: , , , , , , , , , , , , , , , , , , - Circulation Research 2020 cited by 193

  17. Beyond intestinal soap—bile acids in metabolic control

    Authors: , , - Nature Reviews Endocrinology 2014 cited by 454

  18. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction

    Authors: , , , - Gastroenterology 2017 cited by 440

  19. Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dirk Haller, Max Nieuwdorp - Molecular Metabolism 2020 cited by 107

  20. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome

    Authors: , , , , , , , , , , , , , , , , , - npj Biofilms and Microbiomes 2020 cited by 104

  21. Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells

    Authors: , , , , , , , , , , , , , , , , - Cell 2013 cited by 364

  22. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical and Translational Gastroenterology 2018 cited by 190

  23. Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , , - Cell Metabolism 2016 cited by 346

  24. Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

    Authors: , , , , , , , , , , , , , , - European Heart Journal 2020 cited by 128